Facilitating children's contributions in clinic? Findings from an in-depth qualitative study with children with Type

K Curtis-Tyler1

  • 1School of Health Sciences, City University, London, UK. katherine.tyler.1@city.ac.uk

Insights

Young children with Type 1 diabetes have unique insights into their condition and care, often differing from clinical perspectives. Understanding their experiences is key to improving healthcare engagement for pediatric diabetes management.

Area of Science:

  • Pediatric Endocrinology
  • Child Psychology
  • Qualitative Health Research

Background:

  • Policy encourages children's direct involvement in clinic visits.
  • Limited understanding exists regarding younger children's perspectives on Type 1 diabetes and their care.
  • This study addresses the gap in knowledge about children aged 10 and under with Type 1 diabetes.

Purpose of the Study:

  • To explore the lived experiences of children 10 years or younger with Type 1 diabetes.
  • To understand their views on their illness and healthcare interactions.
  • To inform practices that facilitate children's contributions in clinical settings.

Main Methods:

  • Qualitative study involving 17 children under 11 with Type 1 diabetes.
  • Data collected through home visits, discussion groups, and clinic observations.
  • Participants recruited from two outpatient clinics in a multicultural urban setting.

Main Results:

  • Children possess deep experiential knowledge of their condition.
  • Their social positioning significantly impacts their healthcare experiences.
  • Children actively participate in managing their diabetes regimen, often contrary to clinical perceptions.

Conclusions:

  • Clinical settings may not align with children's understanding and experiences of Type 1 diabetes.
  • Findings highlight the need to re-evaluate how children's perspectives are incorporated into care.
  • Supports clinicians in engaging with children's capacities and priorities in long-term illness management.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...